Mark spoke with Perry Cooper of Bloomberg Law about today’s updates to Judge Albright’s standing orders relating to transfer/venue discovery: West Texas Judge Shifts Patent Case Rules After Fed. Cir. Order (subscription required)
Likewise, last Friday Joe shared his thoughts with Scott Graham of Law.com/Texas Lawyer about why CalTech might have chosen to sue Dell and HP in the Waco Division after previously obtaining a $1.1 billion jury verdict in the CDCA: Caltech and Quinn Head to Texas to Sue Dell and HP (subscription required)
Otherwise, here are some links we found interesting this week:
- How SCOTUS will rule on the constitutionality of the appointment of PTAB judges in Arthrex v. Smith & Nephew is one of the patent bar’s most closely-watched subjects. Here with a take on how a different Supreme Court case—Davis v. Saul, concerning the appointment of Social Security judges—may also apply to the PTAB is Steve Brachmann of IPWatchdog: What SCOTUS’[s] Decision to Scrutinize Social Security Act Appointments Clause Case Means for Arthrex
- It’s an age-old question in IP litigation: Is Software Patentable? See what Dylan O. Adams of Davis Wright Tremaine’s Startup Law Blog has to say on the subject.
- We noted last week that the Federal Circuit’s Valeant v. Mylan ruling affects proper venue in ANDA cases. Matthew Weiss, Andrew D. Cohen, and Jordan Engelhardt of Patterson Belknap Webb & Tyler’s Biologics Blog examine Valeant’s implications for similar actions brought under the Biologics Price Competition and Innovation Act (BPCIA): For the First Time Since TC Heartland, the Federal Circuit Addresses Venue in an ANDA Case – the Holding May Also Impact BPCIA Litigation
- Finally, although neither specifically IP-related nor attorney-authored, John Boruvka of discovery services provider Iron Mountain collects some recent useful writeups relating to Legal Discovery in the Time of COVID
Disclaimer: We share these links because we think they’re worth reading. Our doing so does not necessarily imply that we endorse any of the viewpoints expressed by the authors (unless we’re the authors).Like (0)